MAPK3 and Hepatic fibrosis: Moreover, JTE-013 and S1PR2 knockdown significantly reduced the proliferation of cholangiocytes, cholestatic injury, inflammation, and liver fibrosis by acting on ERK1/protein kinase B [11].